Latest Regulatory News

Yari Minerals has announced a substantial 140% increase in its JORC Inferred Coal Resource at the Rolleston South Project in Queensland, now totaling 190 million tonnes. The company is actively drilling to upgrade resource confidence and confirm coal quality, positioning itself for future development.

Yari Minerals has begun a targeted drilling campaign at its Rolleston South Coal Project to confirm semi-soft metallurgical coal and upgrade its resource classification, setting the stage for a 2026 scoping study.

Gold Mountain Limited has reported significant extensions to its rare earth mineralisation at the Irajuba Down Under Project in Brazil, confirming high-grade total and magnet rare earth oxides and paving the way for resource drilling.

Cleanaway Waste Management faced a challenging FY25 with multiple fatalities prompting a safety overhaul, yet reported robust financial growth and reaffirmed FY26 guidance. Strategic acquisitions and operational improvements signal a determined path forward.

Morella Corporation has locked in A$1.4 million in convertible note funding from key shareholders and directors, strengthening its financial position to advance critical minerals exploration and acquisitions.

Alligator Energy Limited has released its comprehensive company constitution, detailing governance, shareholder rights, and director responsibilities under Australian law and ASX rules. This foundational document sets the framework for the company’s operations and compliance.

Aurumin Limited has obtained ASIC approval to extend its 2025 AGM deadline, aligning with the proposed acquisition by Brightstar Resources. This move sets the stage for a significant ownership change pending shareholder approval.

Chalice Mining is progressing its Gonneville Project Pre-Feasibility Study on schedule for November 2025 completion, fully funded and targeting a Final Investment Decision by late 2027 as palladium prices hit a two-year high.

Prominence Energy has extended its agreement to acquire the Gawler Hydrogen Project, allowing more time to secure final regulatory approvals and advance exploration in South Australia.

Radiopharm Theranostics has announced a $40 million equity raise via a two-tranche placement and a Share Purchase Plan (SPP) to fund its clinical programs and working capital. The offer includes new shares at $0.03 each with free attaching options, subject to shareholder approval.

United States Antimony Corporation has proposed acquiring Larvotto Resources in a deal that could create one of the largest antimony producers outside China, offering Larvotto shareholders a significant premium.

United States Antimony Corporation has made a non-binding indicative offer to acquire Larvotto Resources at a significant premium, proposing a strategic merger focused on antimony supply chain security and growth.